4//SEC Filing
Sorrento Therapeutics, Inc. 4
Accession 0001181431-13-055939
CIK 0000850261operating
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 4:50 PM ET
Size
5.4 KB
Accession
0001181431-13-055939
Insider Transaction Report
Form 4
Webb David Ritchie
Director
Transactions
- Award
Stock Options
2013-10-29+11,000→ 29,000 totalExercise: $8.40Exp: 2023-10-29→ Common Stock (11,000 underlying)
Footnotes (1)
- [F1]1/12 of the original number of shares subject to this option shall vest and become exercisable following each one-month period of service starting on September 6, 2013, subject to the reporting person's continued service on the issuer's board of directors on each such date.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000850261
Filing Metadata
- Form type
- 4
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 4:50 PM ET
- Size
- 5.4 KB